Zander Strange joined the Acumen team in February 2023 as Associate Vice President, Business Development and has over 15 years of experience in partnering and capital raising for biotechnology companies. He has extensive expertise in business development, portfolio and commercial strategy and corporate finance. He previously served for four years as Head of Corporate Development at ESCAPE Bio, a venture-backed company developing novel small molecule therapeutics for genetic forms of neurodegeneration, where he led business development and supported over $100 million in private equity fundraising. Before ESCAPE Bio, Zander held corporate development roles at XOMA and Zosano Pharma where he executed partnerships with Novartis, Eli Lilly and Novo Nordisk, among others. He started his career in the investment banking group of Leerink Partners and received a BA from the University of Virginia.